Another recent study showed that the mRNA level of ACTN4 was significantly elevated in breast cancers of the metastatic phenotype, and in triple-negative breast cancer tumors, lacking ER, PR, and HER2 [35]. Here, ERBB2 is linked to breast carcinoma.